No photo of William R Roeske

View Scopus Profile

William R Roeske

  • 7844 Citations
  • 48 h-Index
1968 …2012
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where William R Roeske is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Muscarinic Receptors Medicine & Life Sciences
Pirenzepine Medicine & Life Sciences
Cholinergic Receptors Medicine & Life Sciences
Opioid Receptors Medicine & Life Sciences
Quinuclidinyl Benzilate Medicine & Life Sciences
Rats Chemical Compounds
Muscarinic M1 Receptors Medicine & Life Sciences
Cerebral Cortex Medicine & Life Sciences

Projects 1977 1999

CELLULAR MECHANISMS IN CARDIAC HYPERTROPY

Goldman, S., Roeske, W. R., Runyan, R. B., White, H., Hartshorne, D., Bahl, J. & Morkin, E.

National Institutes of Health

9/1/77 → 8/31/99

Project: Research project

Research Output 1968 2012

  • 7844 Citations
  • 48 h-Index
  • 233 Article
  • 6 Chapter
22 Citations (Scopus)

Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist

Tumati, S., Largent-Milnes, T. M., Keresztes, A., Ren, J., Roeske, W. R., Vanderah, T. W. & Varga, E. V., Mar 2012, In : Journal of Neuroimmunology. 244, 1-2, p. 23-31 9 p.

Research output: Contribution to journal › Article

Cannabinoid Receptor Agonists
Hyperalgesia
Neuroglia
Morphine
Cannabinoid Receptor CB2
20 Citations (Scopus)

Tachykinin NK 1 receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation

Tumati, S., Largent-Milnes, T. M., Keresztes, A. I., Yamamoto, T., Vanderah, T. W., Roeske, W. R., Hruby, V. J. & Varga, E. V., Jun 5 2012, In : European Journal of Pharmacology. 684, 1-3, p. 64-70 7 p.

Research output: Contribution to journal › Article

Neurokinin-1 Receptors
Tachykinins
Microglia
Astrocytes
Opioid Analgesics
13 Citations (Scopus)

Intrathecal PKA-selective siRNA treatment blocks sustained morphine-mediated pain sensitization and antinociceptive tolerance in rats

Tumati, S., Roeske, W. R., Largent-Milnes, T. M., Vanderah, T. W. & Varga, E. V., Jul 15 2011, In : Journal of Neuroscience Methods. 199, 1, p. 62-68 7 p.

Research output: Contribution to journal › Article

Calcitonin Gene-Related Peptide
Hyperalgesia
RNA Interference
Protein Kinases
Morphine
13 Citations (Scopus)

Sustained morphine-mediated pain sensitization and antinociceptive tolerance are blocked by intrathecal treatment with Raf-1-selective siRNA

Tumati, S., Roeske, W. R., Largent-Milnes, T., Wang, R., Vanderah, T. W. & Varga, E. V., Sep 2010, In : British Journal of Pharmacology. 161, 1, p. 51-64 14 p.

Research output: Contribution to journal › Article

Calcitonin Gene-Related Peptide
Morphine
Small Interfering RNA
Pain
Spinal Cord
10 Citations (Scopus)

Sustained morphine treatment augments prostaglandin E2-evoked calcitonin gene-related peptide release from primary sensory neurons in a PKA-dependent manner

Tumati, S., Roeske, W. R., Vanderah, T. W. & Varga, E. V., Dec 1 2010, In : European Journal of Pharmacology. 648, 1-3, p. 95-101 7 p.

Research output: Contribution to journal › Article

Calcitonin Gene-Related Peptide
Sensory Receptor Cells
Cyclic AMP-Dependent Protein Kinases
Dinoprostone
Morphine